Souhaitez-vous accéder aux communiqués récents ?
Créez un compte lecteur dès aujourd’hui afin de suivre les secteurs et les entreprises qui vous intéressent, et configurer votre tableau de bord. SE CONNECTER À UN COMPTE LECTEUR CRÉER UN COMPTE LECTEUR
Polydex Pharmaceuticals Issues First Quarter Financial Results
15 juin 2022 08h45 HE
|
Polydex Pharmaceuticals Limited
TORONTO, June 15, 2022 (GLOBE NEWSWIRE) -- Polydex Pharmaceuticals Limited (Pink Sheets:POLXF) (the “Company”) reports financial results for the first quarter of fiscal 2023, the period ended April...
AITX's Subsidiary Robotic Assistance Devices Invited by Regional Hospital Group and Top 3 Guarding Company to Demonstrate Labor Saving Solutions
09 juin 2022 08h40 HE
|
Artificial Intelligence Technology Solutions, Inc.
Detroit, Michigan, June 09, 2022 (GLOBE NEWSWIRE) -- Artificial Intelligence Technology Solutions, Inc., (OTCPK:AITX), today announced that its wholly owned subsidiary Robotic Assistance Devices,...
XCPCNL Business Services Corporation Announces Appointment of “History” Howard Kennedy Jr. as VP of Consumer Innovation
25 mai 2022 06h30 HE
|
XCPCNL Business Services Corporation
Charlotte, North Carolina, May 25, 2022 (GLOBE NEWSWIRE) -- XCPCNL Business Services Corporation (OTC Pink: XCPL), a venture development business that leverages knowledge, skill, and experience in...
Polydex Pharmaceuticals Issues Year End Financial Results
02 mai 2022 09h58 HE
|
Polydex Pharmaceuticals Limited
TORONTO, May 02, 2022 (GLOBE NEWSWIRE) -- Polydex Pharmaceuticals Limited (Pink Sheets:POLXF) (the “Company”) reports financial results for its fiscal year ended January 31, 2022. All figures are...
Dermatology OTC Medications Market Worth $21.31Bn, Globally, by 2028 at 4.7% CAGR - Exclusive Report by The Insight Partners
25 mars 2022 06h46 HE
|
The Insight Partners
New York, March 25, 2022 (GLOBE NEWSWIRE) -- The Insight Partners published latest research study on “Dermatology OTC Medications Market Forecast to 2028 - COVID-19 Impact and Global Analysis By...
Nutra Pharma Announces First Manufacturing Agreement
23 mars 2022 09h15 HE
|
Nutra Pharma Corp.
Plantation, Florida, March 23, 2022 (GLOBE NEWSWIRE) -- Nutra Pharma Corporation (OTC Pink: NPHC), a biotechnology company marketing Nyloxin®, Pet Pain-Away™, Equine Pain-Away™ and Luxury Feet™ in...
Nutra Pharma Expands Manufacturing Capabilities
17 mars 2022 09h15 HE
|
Nutra Pharma Corp.
Plantation, Florida, March 17, 2022 (GLOBE NEWSWIRE) -- Nutra Pharma Corporation (OTC Pink: NPHC), a biotechnology company marketing Nyloxin®, Pet Pain-Away™, Equine Pain-Away™ and Luxury Feet™ in...
Fastbase (OTC: FBSE) Acquires Strategic Stake in New York-Based Blockchain Technology Company Etheralabs.io
02 mars 2022 16h15 HE
|
fastbase inc
NEW YORK, March 02, 2022 (GLOBE NEWSWIRE) -- Fastbase ("The Company", "we" and "our") (OTC: FBSE) announced today that it has acquired 24.5% of Etheralabs LLC, a New York City-based venture lab and...
Denarius Announces That Its Common Shares Will Begin Trading on the OTCQB Market in the United States on February 17, 2022
16 févr. 2022 07h00 HE
|
Denarius Metals Corp.
TORONTO, Feb. 16, 2022 (GLOBE NEWSWIRE) -- Denarius Metals Corp. (“Denarius” or “the Company”) (TSXV: DSLV; OTCQB: DNRSF) announced today that its common shares will commence trading on the OTCQB...
Brixton Metals Announces DTC Eligibility of its Common Shares
07 févr. 2022 08h00 HE
|
Brixton Metals Corporation
VANCOUVER, British Columbia, Feb. 07, 2022 (GLOBE NEWSWIRE) -- Brixton Metals Corporation (TSX-V: BBB, OTCQB: BBBXF) (the “Company” or “Brixton”) is pleased to announce that its common shares are...